A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AIP SEC filings page.
Arteris, Inc. (AIP) reported $84.6M in revenue over the twelve months to Jun 30, 2026, up 33.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is scaling, but persistent operating losses and negative equity show growth has not yet funded itself.
From FY2024 to FY2025, revenue increased to$70.6M while the operating loss remained$33.1M , so added sales have not yet translated into proportionate operating improvement. FY2025 operating cash flow reached$6.7M despite a net loss of$34.7M , revealing a sharp cash-versus-earnings split rather than self-funded profitability.
Gross margin stayed around
By FY2025, liabilities exceeded assets and negative equity reached
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Arteris, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Arteris, Inc. held $59.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $6.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Arteris, Inc. scores 86/100 among other emerging companies.
Arteris, Inc. had 45M shares outstanding at the end of fiscal year 2025, against 41M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Arteris, Inc. scores 49/100 among other emerging companies.
Arteris, Inc. spent $49.9M on research and development in fiscal year 2025, which was 48.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Arteris, Inc. scores 76/100 among other emerging companies.
Arteris, Inc. reported revenue of $70.6M in fiscal year 2025, against $57.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Arteris, Inc. scores 60/100 among other emerging companies.
Arteris, Inc.'s operations generated $6.7M of cash in fiscal year 2025, against $720K used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Arteris, Inc. scores 92/100 among other emerging companies.
Arteris, Inc.'s cash, cash equivalents and investments came to $59.5M at the end of fiscal year 2025, against $129.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Arteris, Inc. scores 42/100 among other emerging companies.
Arteris, Inc. scores 3.28, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.2B) relative to total liabilities ($129.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Arteris, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Arteris, Inc. reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Arteris, Inc. reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Arteris, Inc. generated $24.1M in revenue in Q2 2026. This represents an increase of 46.2% from the same quarter a year earlier. Against the prior quarter it is up 5.2%.
Arteris, Inc.'s EBITDA was -$12.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 67.4% from the same quarter a year earlier. Against the prior quarter it is down 55.8%.
Arteris, Inc. reported -$14.1M in net income in Q2 2026. This represents a decrease of 54.1% from the same quarter a year earlier. Against the prior quarter it is down 76.7%.
Arteris, Inc. earned -$0.30 per diluted share (EPS) in Q2 2026. This represents a decrease of 36.4% from the same quarter a year earlier. Against the prior quarter it is down 76.5%.
Cash & Balance Sheet
Arteris, Inc. generated $8.6M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 403.3% from the same quarter a year earlier. Against the prior quarter it is up 217.1%.
Arteris, Inc. held $93.3M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Arteris, Inc.'s gross margin was 85.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Arteris, Inc.'s operating margin was -57.6% in Q2 2026, reflecting core business profitability. This is down 7.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 17.1 percentage points.
Arteris, Inc.'s net profit margin was -58.3% in Q2 2026, showing the share of revenue converted to profit. This is down 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 23.6 percentage points.
Arteris, Inc.'s ROE was -20.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 286.4 percentage points.
Capital Allocation
Arteris, Inc. invested $16.8M in research and development in Q2 2026. This represents an increase of 37.7% from the same quarter a year earlier. Against the prior quarter it is up 15.9%.
Arteris, Inc. invested $595K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 67.6% from the same quarter a year earlier. Against the prior quarter it is up 101.7%.
Not reported for Q2 2026.
AIP Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.1M+46.2% | $22.9M+38.7% | $20.1M+30.0% | $17.4M+18.3% | $16.5M+13.2% | $16.5M+27.7% | $15.5M+23.9% | $14.7M+10.8% |
| Cost of Revenue | $3.6M+107.1% | $3.3M+113.0% | $1.9M+18.2% | $1.8M+20.9% | $1.7M+19.5% | $1.5M+4.0% | $1.6M+8.8% | $1.5M+14.1% |
| Gross Profit | $20.5M+39.1% | $19.7M+31.2% | $18.3M+31.3% | $15.6M+18.0% | $14.8M+12.5% | $15.0M+30.7% | $13.9M+25.9% | $13.3M+10.5% |
| R&D Expenses | $16.8M+37.7% | $14.5M+21.9% | $13.2M+14.7% | $12.6M+6.1% | $12.2M+13.6% | $11.9M+9.5% | $11.5M+8.1% | $11.9M+8.4% |
| SG&A Expenses | $6.1M+34.9% | $5.4M+25.3% | $6.4M+56.5% | $4.9M+13.3% | $4.5M-6.8% | $4.3M0.0% | $4.1M-10.7% | $4.3M-3.2% |
| Operating Income | -$13.9M-68.6% | -$9.3M-20.7% | -$8.5M-19.2% | -$8.7M-10.0% | -$8.2M-10.8% | -$7.7M+15.6% | -$7.1M+23.2% | -$7.9M+6.3% |
| EBITDA | -$12.4M-67.4% | -$8.0M-15.9% | -$7.6M-22.7% | -$7.9M-11.3% | -$7.4M-11.4% | -$6.9M+17.3% | -$6.2M+26.2% | -$7.1M+5.5% |
| Interest Expense | $30K-70.0% | $38K-62.0% | -$56K+26.3% | $49K-51.0% | $100K0.0% | $100K+31.6% | -$76K-201.3% | $100K+29.9% |
| Income Tax | $697K-17.6% | -$3.7M-1479.9% | -$19K-101.5% | $380K+513.0% | $846K-13.2% | $268K-27.6% | $1.2M+1.9% | -$92K+76.9% |
| Net Income | -$14.1M-54.1% | -$8.0M+2.0% | -$8.5M-3.7% | -$9.0M-17.0% | -$9.1M-9.4% | -$8.1M+13.6% | -$8.2M+22.2% | -$7.7M+5.7% |
| EPS (Basic) | -$0.30-36.4% | -$0.17+15.0% | -$0.19+5.0% | -$0.21-5.0% | -$0.220.0% | -$0.20+20.0% | -$0.20+28.6% | -$0.20+13.0% |
| EPS (Diluted) | -$0.30-36.4% | -$0.17+15.0% | -$0.19+5.0% | -$0.21-5.0% | -$0.220.0% | -$0.20+20.0% | -$0.20+28.6% | -$0.20+13.0% |
| Diluted Shares (Avg) | 47M+13.0% | 46M+11.5% | N/A | 43M+8.8% | 42M+8.7% | 41M+8.3% | N/A | 39M+9.1% |
AIP Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $224.7M+110.2% | $139.9M+42.3% | $115.0M+8.4% | $107.7M+10.3% | $106.9M+10.9% | $98.3M-3.0% | $106.1M+3.2% | $97.7M-4.4% |
| Current Assets | $146.3M+137.8% | $61.5M+7.2% | $82.4M+19.3% | $61.0M-2.8% | $61.5M+4.5% | $57.4M-7.1% | $69.1M+18.2% | $62.8M+1.3% |
| Cash & Equivalents | $93.3M+479.3% | $11.7M-28.7% | $33.9M+147.7% | $17.4M-2.3% | $16.1M-27.2% | $16.4M-37.3% | $13.7M-0.1% | $17.8M-4.3% |
| Short-Term Investments | $28.8M+31.7% | $26.4M+1.9% | $20.7M-31.4% | $21.6M-30.1% | $21.9M-7.5% | $25.9M+38.8% | $30.2M+9.8% | $30.8M+11.2% |
| Accounts Receivable | $15.2M-18.8% | $14.7M+43.1% | $19.2M-6.9% | $16.5M+89.1% | $18.8M+109.6% | $10.3M-16.3% | $20.6M+71.7% | $8.7M-16.0% |
| Long-Term Investments | $1.2M-92.5% | $3.8M-70.4% | $4.9M-41.8% | $17.2M+195.2% | $15.9M+95.8% | $12.8M+48.6% | $8.5M-27.9% | $5.8M-43.2% |
| Goodwill | $35.3M+744.9% | $35.2M+742.4% | $4.2M0.0% | $4.2M0.0% | $4.2M0.0% | $4.2M0.0% | $4.2M0.0% | $4.2M0.0% |
| Total Liabilities | $157.0M+37.3% | $137.3M+33.1% | $129.7M+20.8% | $119.2M+24.8% | $114.4M+25.6% | $103.1M+12.3% | $107.3M+22.4% | $95.5M+19.2% |
| Current Liabilities | $93.3M+49.2% | $84.5M+49.5% | $73.2M+23.5% | $66.8M+23.2% | $62.6M+20.9% | $56.5M+13.5% | $59.3M+27.8% | $54.2M+21.8% |
| Non-Current Liabilities | $63.7M+22.8% | $52.8M+13.2% | $56.5M+17.5% | $52.4M+26.9% | $51.9M+31.7% | $46.6M+11.0% | $48.0M+16.3% | $41.3M+15.9% |
| Total Equity | $67.7M+998.8% | $2.6M+153.7% | -$14.6M-1131.6% | -$11.4M-618.3% | -$7.5M-242.7% | -$4.8M-150.5% | -$1.2M-107.9% | $2.2M-90.0% |
| Retained Earnings | -$193.7M-25.6% | -$179.6M-23.9% | -$171.6M-25.4% | -$163.1M-26.8% | -$154.1M-27.4% | -$145.0M-28.7% | -$136.9M-32.6% | -$128.7M-38.8% |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
AIP Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.2M+470.6% | -$7.1M-346.9% | $3.2M+220.5% | $3.2M+183.9% | -$2.5M-899.0% | $2.9M+499.6% | -$2.6M+11.7% | $1.1M+140.0% |
| Depreciation & Amortization | $1.5M+79.3% | $1.3M+59.5% | $844K-5.0% | $843K-0.1% | $845K+6.0% | $844K+1.3% | $888K+7.1% | $844K-12.5% |
| Stock-Based Compensation | $6.3M+41.1% | $5.5M+27.8% | N/A | $5.0M+12.9% | $4.5M+19.6% | $4.3M+17.9% | N/A | $4.4M+18.2% |
| Capital Expenditures | $595K+67.6% | $295K+61.2% | $134K+168.0% | $716K+2209.7% | $355K+655.3% | $183K-6.6% | $50K-88.3% | $31K-90.9% |
| Free Cash Flow | $8.6M+403.3% | -$7.4M-374.8% | $3.0M+213.2% | $2.5M+126.4% | -$2.8M-1175.8% | $2.7M+852.7% | -$2.7M+21.3% | $1.1M+134.7% |
| Investing Cash Flow | -$372K-152.8% | -$16.0M-13162.8% | $13.1M+778.2% | -$1.6M+64.9% | $705K+116.2% | -$121K-101.0% | -$1.9M-40.9% | -$4.6M-25.8% |
| Financing Cash Flow | $72.8M+4724.7% | $882K+1796.2% | $142K-65.7% | -$181K+76.6% | $1.5M+2641.8% | -$52K-218.2% | $414K+170.9% | -$775K+35.8% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AIP Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 85.0%-4.4pp | 85.8%-4.9pp | 90.8%+0.9pp | 89.9%-0.2pp | 89.4%-0.6pp | 90.8%+2.1pp | 89.8%+1.4pp | 90.1%-0.3pp |
| Operating Margin | -57.6%-7.7pp | -40.6%+6.1pp | -42.0%+3.8pp | -50.1%+3.8pp | -50.0%+1.1pp | -46.6%+23.9pp | -45.9%+28.1pp | -53.8%+9.9pp |
| Net Margin | -58.3%-2.9pp | -34.7%+14.4pp | -42.2%+10.7pp | -51.6%+0.6pp | -55.3%+1.9pp | -49.1%+23.5pp | -53.0%+31.3pp | -52.3%+9.2pp |
| Return on Equity | -20.8% | -307.2% | N/A | N/A | N/A | N/A | N/A | -348.0%-311.0pp |
| Return on Assets | -6.3%+2.3pp | -5.7%+2.6pp | -7.4%+0.3pp | -8.3%-0.5pp | -8.5%+0.1pp | -8.3%+1.0pp | -7.7%+2.5pp | -7.9%+0.1pp |
| Current Ratio | 1.57+0.6x | 0.73-0.3x | 1.130.0x | 0.91-0.2x | 0.98-0.2x | 1.02-0.2x | 1.17-0.1x | 1.16-0.2x |
| Debt-to-Equity | 2.32 | 52.99 | N/A | N/A | N/A | N/A | N/A | 43.23+39.6x |
| Asset Turnover | 0.110.0x | 0.160.0x | 0.180.0x | 0.160.0x | 0.150.0x | 0.170.0x | 0.150.0x | 0.150.0x |
| FCF Margin | 35.7%+52.9pp | -32.1%-48.3pp | 15.1%+32.4pp | 14.2%+6.8pp | -17.2%-19.0pp | 16.2%+14.0pp | -17.3%+9.9pp | 7.4%+31.1pp |
Note: Shareholder equity is negative (-$14.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Arteris, Inc. AIP | FY2025 | $70.6M | -$34.7M | -49.2% | $1.2B | 68/100 |
| SEALSQ Corp LAES | FY2025 | $18.3M | -$34.2M | N/A | $533.1M | 45/100 |
| POET Technologies Inc. POET | FY2025 | $1.1M | -$63.0M | N/A | $1.3B | 19/100 |
| NVE Corp NVEC | FY2026 | $26.3M | $15.2M | 57.7% | $539.0M | 82/100 |
| CEVA Inc. CEVA | FY2025 | $109.6M | -$10.6M | -9.7% | $1.0B | 74/100 |
| SkyWater Technology, Inc. SKYT | FY2025 | $442.1M | $118.9M | 26.9% | $1.6B | 40/100 |
Where Arteris, Inc. Ranks
Frequently Asked Questions
What is Arteris, Inc.'s annual revenue?
Arteris, Inc. (AIP) reported $70.6M in total revenue for fiscal year 2025. This represents a 22.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Arteris, Inc.'s revenue growing?
Arteris, Inc. (AIP) revenue grew by 22.3% year-over-year, from $57.7M to $70.6M in fiscal year 2025.
Is Arteris, Inc. profitable?
No, Arteris, Inc. (AIP) reported a net income of -$34.7M in fiscal year 2025, with a net profit margin of -49.2%.
What is Arteris, Inc.'s EBITDA?
Arteris, Inc. (AIP) had EBITDA of -$29.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Arteris, Inc.'s gross margin?
Arteris, Inc. (AIP) had a gross margin of 90.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Arteris, Inc.'s operating margin?
Arteris, Inc. (AIP) had an operating margin of -46.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Arteris, Inc.'s net profit margin?
Arteris, Inc. (AIP) had a net profit margin of -49.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Arteris, Inc.'s free cash flow?
Arteris, Inc. (AIP) generated $5.3M in free cash flow during fiscal year 2025. This represents a 612.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Arteris, Inc.'s operating cash flow?
Arteris, Inc. (AIP) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Arteris, Inc.'s total assets?
Arteris, Inc. (AIP) had $115.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Arteris, Inc.'s capital expenditures?
Arteris, Inc. (AIP) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Arteris, Inc. spend on research and development?
Arteris, Inc. (AIP) invested $49.9M in research and development during fiscal year 2025.
What is Arteris, Inc.'s current ratio?
Arteris, Inc. (AIP) had a current ratio of 1.13 as of fiscal year 2025, which is considered adequate.
What is Arteris, Inc.'s return on assets (ROA)?
Arteris, Inc. (AIP) had a return on assets of -30.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Arteris, Inc.'s P/E ratio?
Arteris, Inc. (AIP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.2B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Arteris, Inc.'s price-to-sales ratio?
Arteris, Inc. (AIP) trades at 14.3x sales, its market capitalization divided by revenue of $84.6M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.2B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is Arteris, Inc.'s debt-to-equity ratio negative or not reported?
Arteris, Inc. (AIP) has negative shareholder equity of -$14.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Arteris, Inc.'s Altman Z-Score?
Arteris, Inc. (AIP) has an Altman Z-Score of 3.28, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Arteris, Inc.'s Piotroski F-Score?
Arteris, Inc. (AIP) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Arteris, Inc.'s earnings high quality?
Arteris, Inc. (AIP) reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Arteris, Inc. cover its interest payments?
Arteris, Inc. (AIP) reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Arteris, Inc.?
Arteris, Inc. (AIP) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.